Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

The modified Direct Hair Transplantation method is effective for treating baldness with better graft survival and less damage than standard techniques.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Hair loss gene linked to prostate issues.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Higher DHT in male baldness may protect against prostate cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Finasteride is effective and safe for long-term treatment of hair loss in Japanese men.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Melatonin treatment increases wool production and improves fiber quality in angora rabbits.

Lower melatonin levels are linked to more skin aging.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Platelet-rich plasma (PRP) can significantly improve melasma, a skin pigmentation disorder, but may not add benefits when used with certain other treatments.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Certain genetic changes in the KAP22-1 gene are linked to better wool quality in Egyptian sheep.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.